A phase I dose expansion study of NBTXR3, radiation enhancing hafnium oxide nanoparticles, for the treatment of cisplatin-ineligible locally advanced HNSCC patients

Saved in:
Bibliographic Details
Published in:Journal of geriatric oncology 2021-12, Vol.12 (8), p.S9-S10
Main Authors: Le Tourneau, C., Calugaru, V., Moreno, V., Calvo, E., Liem, X., Salas, S., Doger, B., Jouffroy, T., Mirabel, X., Rodriguez, J., Chilles, A., Bernois, K., Fakhry, N., Wong Hee Kam, S., Hoffmann, C.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1879-4068
DOI:10.1016/S1879-4068(21)00346-5